High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy-Reference-Cited by-同舟云学术

High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy

Published:2004-02-01 Issue:3 Volume:113 Page:425-433
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Gross David-Alexandre,Graff-Dubois Stéphanie,Opolon Paule,Cornet Sébastien,Alves Pedro,Bennaceur-Griscelli Annelise,Faure Olivier,Guillaume Philippe,Firat Hüseyin,Chouaib Salem,Lemonnier François A.,Davoust Jean,Miconnet Isabelle,Vonderheide Robert H.,Kosmatopoulos Kostas

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference48 articles.

1. Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

2. Human tumor antigens recognized by T cells

3. Tolerance to p53 by A2.1-restricted Cytotoxic T Lymphocytes

4. Self-Tolerance to the Murine Homologue of a Tyrosinase-Derived Melanoma Antigen

5. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of HLA‐restricted Cytotoxic T Lymphocyte Epitopes of B Cell Maturation Antigen as Promising Peptide Vaccine Candidates for Preventive and Therapeutic Strategies in Multiple Myeloma;Advanced Therapeutics;2023-11-29

2. Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective;Current Opinion in Endocrinology, Diabetes & Obesity;2022-07-02

3. Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors;Journal for ImmunoTherapy of Cancer;2021-07

4. Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in “Immune Desert” NSCLC;Cancers;2021-04-01

5. An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection;Journal of Clinical Investigation;2021-02-01